Literature DB >> 4015324

Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia.

J F Hiatt, T C Floyd, P H Katz, I Feinberg.   

Abstract

Very low levels of visually scored stage 4 sleep are found in 40% to 50% of acute and chronic schizophrenics. Stage 4 is a visual estimate of high-amplitude delta (0.5 to 3 Hz) electroencephalographic waves; these waves can now be measured directly and reliably by computer. In this pilot study, we carried out such measurement in the successive non-rapid-eye-movement periods (NREMPs). We also sampled and measured visually sleep spindles by NREMP; spindles constitute a second distinctive feature of the NREM electroencephalogram. In five unmedicated, recently rehospitalized schizophrenic patients we found reduced delta amplitude and abundance (and increased spindle density) in NREMP1 (also called "REM latency") as compared with ambulatory normal controls. NREMP1 was also abnormally short with an average length similar to that reported for major depression. These striking abnormalities of NREM sleep may underlie the abnormal rapid eye movement distributions sometimes found in schizophrenic and depressed patients. Further studies are required to evaluate the relation of these NREM abnormalities to psychopathology (and hence their utility as biological "markers") and to rule out confounding effects of hospitalization or undetected napping.

Entities:  

Mesh:

Year:  1985        PMID: 4015324     DOI: 10.1001/archpsyc.1985.01790310059007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  31 in total

Review 1.  Basic Neuroscience Illuminates Causal Relationship Between Sleep and Memory: Translating to Schizophrenia.

Authors:  Ana Pocivavsek; Laura M Rowland
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

Review 2.  Sleep-dependent memory consolidation and its implications for psychiatry.

Authors:  Monique Goerke; Notger G Müller; Stefan Cohrs
Journal:  J Neural Transm (Vienna)       Date:  2015-10-30       Impact factor: 3.575

Review 3.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.

Authors:  D B Boivin
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

4.  Sleep in patients with schizophrenia.

Authors:  Fabio Ferrarelli
Journal:  Curr Sleep Med Rep       Date:  2015-04-11

5.  Does ritanserin, a potent serotonin-S2 antagonist, restore energetic functions during the night?

Authors:  P A Janssen
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

6.  Reduced sleep spindles and spindle coherence in schizophrenia: mechanisms of impaired memory consolidation?

Authors:  Erin J Wamsley; Matthew A Tucker; Ann K Shinn; Kim E Ono; Sophia K McKinley; Alice V Ely; Donald C Goff; Robert Stickgold; Dara S Manoach
Journal:  Biol Psychiatry       Date:  2011-10-02       Impact factor: 13.382

Review 7.  Psychiatric disorders and sleep.

Authors:  Andrew D Krystal
Journal:  Neurol Clin       Date:  2012-11       Impact factor: 3.806

Review 8.  Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective.

Authors:  John H Krystal; Alan Anticevic; Genevieve J Yang; George Dragoi; Naomi R Driesen; Xiao-Jing Wang; John D Murray
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

9.  Fast sleep spindle reduction in schizophrenia and healthy first-degree relatives: association with impaired cognitive function and potential intermediate phenotype.

Authors:  Claudia Schilling; Manuel Schlipf; Simone Spietzack; Franziska Rausch; Sarah Eisenacher; Susanne Englisch; Iris Reinhard; Leila Haller; Oliver Grimm; Michael Deuschle; Heike Tost; Mathias Zink; Andreas Meyer-Lindenberg; Michael Schredl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-26       Impact factor: 5.270

10.  Does abnormal sleep impair memory consolidation in schizophrenia?

Authors:  Dara S Manoach; Robert Stickgold
Journal:  Front Hum Neurosci       Date:  2009-09-01       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.